Latest Breaking News On - Epeius biotechnologies corp - Page 1 : comparemela.com

Gene Therapy Market to be Worth $10 0 Billion by 2028 with CAGR of 20 4%: Grand View Research, Inc

SAN FRANCISCO, Aug. 11, 2022 /PRNewswire/ The global gene therapy market size is expected to reach USD 10.0 billion by 2028 registering a CAGR of 20.4% during the forecast period, according

United statesGrand viewSan franciscoKostenloser wertpapierhandelGensight biologicsOxford biomedicaAsia pacificBio zyntegloSherry jamesRegenxbio incEpeius biotechnologies corpTaxus cardium pharmaceuticals group incShanghai sunway biotech co ltdBristol myers squibb companyView research helps fortuneBenitec biopharma ltd

Global Gene Therapy Market Report 2022: A $21 25 Billion

Dublin, June 20, 2022 (GLOBE NEWSWIRE) The "Gene Therapy Global Market Report 2022: By Gene, By Vector, By Application, By End-User" report has been.

United statesUnited kingdomBenitech biopharmaGensight biologicsOxford biomedicaGenetic technologies corporationEpeius biotechnologies corpCelgene corporationShanghai sunway biotech co ltdBristol myers suibb companySibiono genetech co ltdTaxus cardium pharmaceuticals groupBritain national health serviceAmerican cancer societyTherapy global market reportNational health

Global Gene Therapy Markets Report 2021-2030: Antigen, Cytokine, Suicide Gene, Viral Vector, Non-Viral Vector, Oncological, Rare Diseases, Cardiovascular, Neurological Disorders, Infectious Diseases

Global Gene Therapy Markets Report 2021-2030: Antigen, Cytokine, Suicide Gene, Viral Vector, Non-Viral Vector, Oncological, Rare Diseases, Cardiovascular, Neurological Disorders, Infectious Diseases
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBenitech biopharmaGensight biologicsOxford biomedicaLaura woodRegenxbio incEpeius biotechnologies corpTaxus cardium pharmaceuticals group incCelgene corporationShanghai sunway biotech co ltdBristol myers suibb companySarepta therapeutics incBluebird bio incShrine plcAmerican cancer society

Global Gene Therapy Market Report 2020-2030 Featuring Novartis, Bluebird Bio, Spark Therapeutics, Audentes Therapeutics, Voyager Therapeutics, UniQure, Celgene, Cellectis and Sangamo Therapeutics

Share this article Share this article ResearchAndMarkets.com s offering. Gene Therapy Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global gene therapy market market. Major players in the gene therapy market are Novartis AG, Bluebird Bio, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A. and Sangamo Therapeutics. The global gene therapy market is expected to decline from $3.22 billion in 2019 to $3.18 billion in 2020 at a compound annual growth rate (CAGR) of -1.30%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The market is then expected to re

United statesUnited kingdomBenitech biopharmaGensight biologicsOxford biomedicaLaura woodRegenxbio incEpeius biotechnologies corpTaxus cardium pharmaceuticals group incCelgene corporationShanghai sunway biotech co ltdBristol myers suibb companySarepta therapeutics incBluebird bio incShrine plcCustom research

Global Gene Therapy Market Report 2020-2030: COVID-19 Growth and Change Impacts – ResearchAndMarkets com

ResearchAndMarkets.com’s offering. Gene Therapy Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global gene therapy market. Major players in the gene therapy market are Novartis AG, Bluebird Bio, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A. and Sangamo Therapeutics. The global gene therapy market is expected to decline from $3.22 billion in 2019 to $3.18 billion in 2020 at a compound annual growth rate (CAGR) of -1.30%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The market is then expected to recover and reach $6.84 billion in 2023 at a CAGR

United statesUnited kingdomBenitech biopharmaGensight biologicsOxford biomedicaLaura woodRegenxbio incEpeius biotechnologies corpTaxus cardium pharmaceuticals group incCelgene corporationShanghai sunway biotech co ltdBristol myers suibb companySarepta therapeutics incBluebird bio incShrine plcGenetic technologies corporation